Callan JMB Inc. Common Stock (CJMB)

FairStock Score: 25/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for durable economics and a margin of safety. Callan JMB provides thermal management logistics for the life sciences, a niche where reliability matters. But the numbers do not show a durable moat. Revenue fell from $13.2M in the fiscal year ended 2023-12-31 to $6.6M in the fiscal year ended 2024-12-31 and $5.7M in the fiscal year ended 2025-12-31. In the fiscal year ended 2025-12-31, the company lost $8.0M, after net income of $2.2M in the fiscal year ended 2023-12-31 and a net loss of $2.3M in the fiscal year ended 2024-12-31. The latest filings show continued weakness: in fiscal Q1 2026, the quarter ended 2026-03-31, revenue was $1.1M and net loss was $3.2M; in fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $1.4M and net loss was $1.2M. Free cash flow is -$4.7M on a trailing basis, a -38.3% FCF yield against the $12.4M market cap. The balance sheet looks stretched: D/E 3.14, Altman Z -3.23, Piotroski 4/9. ROE is -300.33% and ROCE is -64.24%, meaning capital is being consumed. At the 2026-10-13 close of $2.15, the P/B is 17.92 and the P/E is negative. For Graham, negative earnings and a high book multiple leave no calculable margin of safety. As a Buffett-style investor, I see an 18-employee company in a specialized but vulnerable niche. The Lynch category is TURNAROUND — loss in the latest year after earlier profits. Turnarounds can work, but only if cash flows stabilize and debt is manageable. Here revenue is shrinking and losses persist. I would want evidence of sustained positive cash flow and a repaired balance sheet before calling it cheap.

In plain English: Callan JMB makes temperature-controlled shipping systems for life sciences companies, such as cell therapies and vaccines. The business looks weak right now: sales have shrunk, it is losing money, and it burns cash. At the latest close of $2.15, the price looks expensive compared with its losses and what the books show it owns.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer